Suppr超能文献

林奇综合征女性中子宫内膜取样在子宫内膜癌早期检测中的附加价值。

The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome.

机构信息

Department of Gynecologic Oncology, University of Groningen, University Medical Center Groningen, The Netherlands.

出版信息

Gynecol Oncol. 2013 Nov;131(2):304-8. doi: 10.1016/j.ygyno.2013.05.032. Epub 2013 Jun 13.

Abstract

OBJECTIVE

Based on previous studies, standard gynecological screening consisting of annual transvaginal ultrasonography (TVU) was added with endometrial sampling in women with Lynch syndrome (LS). The aim of this study was to evaluate the additional value of endometrial sampling in detecting (pre)malignancies of the endometrial tissue in women with LS or first-degree relatives.

METHODS

All women above 30 years of age with LS or first-degree relatives at 50% risk of LS are offered annual gynecological screening in our family cancer clinic. Endometrial screening results from January 2003-December 2007 (period I: standard screening by transvaginal sonography and serum CA125) were compared with screening results from January 2008-June 2012 (period II: standard screening added with endometrial sampling).

RESULTS

Seventy five women (300 patient years) were screened annually. There were 266 screening visits, 117 in period I and 149 in period II. In period I, four premalignant endometrial lesions were detected and one endometrial carcinoma (FIGO stage IB). In period II, two premalignancies were found. None of the lesions would have been missed without standard endometrial sampling. No interval endometrial cancers were detected in this study.

CONCLUSION

In this study, annual endometrial screening seems an effective screening tool in the detection of premalignancies and early endometrial cancer in women with LS. Adding standard endometrial sampling to annual TVU has no additional value in the early detection of (pre)malignant endometrial lesions in women with LS in this study.

摘要

目的

基于以往的研究,对林奇综合征(LS)患者或其一级亲属,在标准妇科筛查(包括每年经阴道超声检查[TVU])的基础上增加子宫内膜取样。本研究旨在评估子宫内膜取样在检测 LS 患者或其一级亲属的子宫内膜组织(良)恶性病变中的附加价值。

方法

我们在家族癌症诊所对所有年龄大于 30 岁的 LS 患者或 LS 风险为 50%的一级亲属,提供每年的妇科筛查。比较 2003 年 1 月至 2007 年 12 月(第 I 期:经阴道超声和血清 CA125 标准筛查)和 2008 年 1 月至 2012 年 6 月(第 II 期:标准筛查加子宫内膜取样)的筛查结果。

结果

共 75 例患者(300 名患者年)接受每年筛查。共有 266 次筛查就诊,第 I 期 117 次,第 II 期 149 次。第 I 期发现 4 例癌前子宫内膜病变和 1 例子宫内膜癌(FIGO 分期 IB)。第 II 期发现 2 例癌前病变。如果没有标准的子宫内膜取样,这些病变都有可能被遗漏。本研究中未发现间隔期子宫内膜癌。

结论

在这项研究中,每年进行子宫内膜筛查似乎是一种有效的筛查工具,可用于检测 LS 患者的癌前病变和早期子宫内膜癌。在本研究中,在每年 TVU 的基础上增加标准子宫内膜取样,对于 LS 患者(良)恶性子宫内膜病变的早期检测没有额外的价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验